Seelos Therapeutics Inc (SEEL)

[mean gene]

I know that management seems to be in apt at times however, I believe that all of these situations were addressed with the FDA meeting they had last year. The device situation was a surprise to management at that meeting ,so I'm sure if there were other issues they would have been brought up at that meeting. The purpose of that meeting last year was to make sure that all the i's are dotted and all the t's are crossed, we have to believe that management wants to get it right this time.